DLH (NASDAQ:DLHC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. The brokerage presently has a $7.00 price target on the business services provider’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 8.70% from the company’s current price.

According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “

Several other equities analysts also recently commented on DLHC. ValuEngine downgraded shares of DLH from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Canaccord Genuity reiterated a “buy” rating and set a $7.00 price target on shares of DLH in a report on Friday, October 13th. Finally, TheStreet upgraded shares of DLH from a “c” rating to a “b-” rating in a report on Wednesday, November 1st. One analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $7.17.

Shares of DLH (DLHC) traded up $0.21 during trading hours on Friday, reaching $6.44. 1,404 shares of the company traded hands, compared to its average volume of 14,583. The company has a market cap of $71.46, a P/E ratio of 22.82 and a beta of 0.67. DLH has a one year low of $4.10 and a one year high of $7.07.

In other DLH news, major shareholder Wynnefield Partners Small Cap sold 50,000 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $6.11, for a total value of $305,500.00. The sale was disclosed in a filing with the SEC, which is available through this link. 21.60% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DLHC. Renaissance Technologies LLC boosted its stake in shares of DLH by 12.4% during the first quarter. Renaissance Technologies LLC now owns 120,140 shares of the business services provider’s stock valued at $649,000 after purchasing an additional 13,250 shares in the last quarter. Essex Investment Management Co. LLC boosted its stake in shares of DLH by 19.8% during the second quarter. Essex Investment Management Co. LLC now owns 28,844 shares of the business services provider’s stock valued at $155,000 after purchasing an additional 4,758 shares in the last quarter. Commonwealth Equity Services Inc bought a new position in shares of DLH during the third quarter valued at approximately $2,342,000. Finally, Dimensional Fund Advisors LP bought a new position in shares of DLH during the third quarter valued at approximately $121,000. Hedge funds and other institutional investors own 55.64% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “DLH (DLHC) Stock Rating Upgraded by Zacks Investment Research” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/08/dlh-dlhc-stock-rating-upgraded-by-zacks-investment-research.html.

About DLH

DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veteransÂ’ health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.

Get a free copy of the Zacks research report on DLH (DLHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DLH Holdings Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH Holdings Corp. and related companies with MarketBeat.com's FREE daily email newsletter.